Your browser doesn't support javascript.
loading
The diagnostic accuracy of HbA1c , compared to the oral glucose tolerance test, for screening for type 2 diabetes mellitus in Africa-A systematic review and meta-analysis.
Chivese, Tawanda; Hirst, Jennifer; Matizanadzo, Joshua T; Custodio, Michael; Farmer, Andrew; Norris, Shane; Levitt, Naomi.
Afiliação
  • Chivese T; Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar.
  • Hirst J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Matizanadzo JT; Department of Public Health and Primary Care, Brighton & Sussex Medical School, Brighton, UK.
  • Custodio M; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Farmer A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Norris S; SAMRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Medicine and Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Levitt N; Chronic Disease Initiative for Africa, Department of Medicine, Faculty of Medicine and Health Sciences, University of Cape Town, Cape Town, South Africa.
Diabet Med ; 39(4): e14754, 2022 04.
Article em En | MEDLINE | ID: mdl-34854127
ABSTRACT

OBJECTIVE:

To assess the diagnostic accuracy of glycated haemoglobin A1c (HbA1c ), compared to fasting plasma glucose (FPG) and the oral glucose tolerance test (OGTT), in screening for type 2 diabetes (T2D) in Africa.

METHODS:

We systematically searched databases for studies that compared the HbA1c to either the OGTT, or the FPG for T2D diagnosis were included. The QUADAS 2 tool was used for assessing the quality of included studies. We used the split component synthesis (SCS) method for the meta-analysis of diagnostic accuracy studies to pool the studies for meta-analysis of sensitivity and specificity, primarily at the HbA1c ≥48 mmol/mol (6.5%) cut-off and at other cut-offs. We assessed heterogeneity using the I2  statistic and publication bias using Doi plots.

RESULTS:

Eleven studies, from seven African countries, with 12,925 participants, were included. Against the OGTT, HbA1c ≥48 mmol/mol (6.5%) had a pooled sensitivity of 57.7% (95% confidence interval [CI] 43.4-70.9) and specificity of 92.3% (95% CI 83.9-96.5). Against the FPG, HbA1c ≥48 mmol/mol (6.5%) had a pooled sensitivity of 64.5% (95% CI 50.5-76.4) and specificity of 94.3% (95% CI 87.9-97.5). The highest sensitivity for HbA1c , against the OGTT, was at the 42 mmol/mol (6.0%) cut-off.

CONCLUSION:

In Africa, the HbA1c ≥48 mmol/mol (6.5%) cut-off may miss almost half of the individuals with T2D based on blood glucose measures.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Diabetes Mellitus Tipo 2 Tipo de estudo: Diagnostic_studies / Screening_studies / Systematic_reviews Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Diabet Med Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Qatar

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Diabetes Mellitus Tipo 2 Tipo de estudo: Diagnostic_studies / Screening_studies / Systematic_reviews Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Diabet Med Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Qatar